LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Incidence of Bell Palsy in Patients With COVID-19.

    Tamaki, Akina / Cabrera, Claudia I / Li, Shawn / Rabbani, Cyrus / Thuener, Jason E / Rezaee, Rod P / Fowler, Nicole

    JAMA otolaryngology-- head & neck surgery

    2021  Volume 147, Issue 8, Page(s) 767–768

    MeSH term(s) Bell Palsy/epidemiology ; Bell Palsy/virology ; COVID-19/complications ; Female ; Humans ; Incidence ; Male ; Recurrence ; Retrospective Studies ; SARS-CoV-2 ; United States/epidemiology
    Language English
    Publishing date 2021-06-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2701825-8
    ISSN 2168-619X ; 2168-6181
    ISSN (online) 2168-619X
    ISSN 2168-6181
    DOI 10.1001/jamaoto.2021.1266
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Has Coranavirus Disease 2019 Changed the Incidence and Outcome of Bell's Palsy?

    Lassaletta, Luis / Sánchez-Cuadrado, Isabel / Mato-Patino, Teresa / Peñarrocha, Julio / Angélica Rivera-Núñez, María / María Torres Santos-Olmo, Rosario / Gavilán, Javier / Manuel Morales-Puebla, José / Group, Covid Orl Hulp Collaborative

    The journal of international advanced otology

    2024  Volume 20, Issue 1, Page(s) 19–25

    Abstract: ... during the pandemic. (2) To investigate whether the outcomes of patients with BP and COVID-19 infection ... positive PCR and facial function outcomes. Of the 162 patients, 105 (67%) had received COVID-19 vaccine ... Background: Objectives: (1) To determine whether the incidence of Bell's Palsy (BP) increased ...

    Abstract Background: Objectives: (1) To determine whether the incidence of Bell's Palsy (BP) increased during the pandemic. (2) To investigate whether the outcomes of patients with BP and COVID-19 infection or vaccination differ from those in the pre-pandemic era.
    Methods: Patients with BP were studied in 2 periods retrospectively (March 2021-March 2022 and August 2018-August 2019). A prospective study from March 2021 to March 2022 was also performed. Primary outcome was grade ≤Ⅱ in the House-Brackmann (HB) and/or >70 in the Sunnybrook facial grading system (SFGS) scales at the 12-week visit. Reverse transcriptase polymerase chain reaction (PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and enzyme-linked immunosorbent assay-based SARS-CoV-2 immuonoglobulin G (IgG) test (blood) were measured.
    Results: About 162 and 196 patients with BP were identified between March 2021 and March 2022 and August 2018 and August 2019, respectively. Forty-seven patients (29%) entered the prospective study; 85% had HB grades I or II, while 92% had an SFGS score of 71-100 at the last visit. Only 3 patients (6.5%) had a positive PCR during the initial episode, whereas 35 patients (77%) had positive IgG SARS-CoV-2. There was no association between positive PCR and facial function outcomes. Of the 162 patients, 105 (67%) had received COVID-19 vaccine. In 23 of them (22%), the paralysis appeared within the first 30 days after a vaccine dose.
    Conclusion: Coronavirus disease 2019 did not increase the incidence of BP. A direct association between the coronavirus and BP outcome cannot be established. The considerable number of patients developing BP within the first month suggests a possible association between COVID-19 vaccines and BP.
    MeSH term(s) Humans ; Bell Palsy/epidemiology ; COVID-19 Vaccines ; Retrospective Studies ; Prospective Studies ; Incidence ; Facial Paralysis ; COVID-19/epidemiology ; SARS-CoV-2 ; Immunoglobulin G
    Chemical Substances COVID-19 Vaccines ; Immunoglobulin G
    Language English
    Publishing date 2024-03-07
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 2561231-1
    ISSN 2148-3817 ; 1308-7649 ; 2148-3817
    ISSN (online) 2148-3817
    ISSN 1308-7649 ; 2148-3817
    DOI 10.5152/iao.2024.231254
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Incidence of Bell's palsy after coronavirus disease (COVID-19) vaccination: a systematic review and meta-analysis.

    Soltanzadi, Atena / Mirmosayyeb, Omid / Momeni Moghaddam, Amin / Ghoshouni, Hamed / Ghajarzadeh, Mahsa

    Neurologia

    2023  

    Abstract: ... of origin, sex, type of vaccines, and the number of patients who developed Bell's palsy after COVID-19 ... Objective: To estimate the pooled incidence of Bell's palsy after COVID-19 vaccination.: Methods ... The incidence of Bell's palsy after COVID-19 vaccines was ignorable. The odds of developing Bell's palsy after ...

    Abstract Objective: To estimate the pooled incidence of Bell's palsy after COVID-19 vaccination.
    Methods: PubMed, Scopus, EMBASE, Web of Science, and Google Scholar were searched by 2 independent researchers. We also searched the grey literature including references of the references and conference abstracts. We extracted data regarding the total number of participants, first author, publication year, the country of origin, sex, type of vaccines, and the number of patients who developed Bell's palsy after COVID-19 vaccination.
    Results: The literature search revealed 370 articles, subsequently deleting duplicates 227 remained. After careful evaluation of the full texts, 20 articles remained for meta-analysis. The most commonly administered vaccines were Pfizer followed by Moderna. In total, 4.54e+07 individuals received vaccines against COVID-19, and 1739 cases developed Bell's palsy. In nine studies, controls (individuals without vaccination) were enrolled. The total number of controls was 1 809 069, of whom 203 developed Bell's palsy. The incidence of Bell's palsy after COVID-19 vaccines was ignorable. The odds of developing Bell's palsy after COVID-19 vaccines was 1.02 (95% CI: 0.79-1.32) (I2 = 74.8%, P < .001).
    Conclusion: The results of this systematic review and meta-analysis show that the incidence of peripheral facial palsy after COVID-19 vaccination is ignorable and vaccination does not increase the risk of developing Bell's palsy. Maybe, Bell's palsy is a presenting symptom of a more severe form of COVID-19, so clinicians must be aware of this.
    Language English
    Publishing date 2023-07-09
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 2654369-2
    ISSN 2173-5808 ; 2173-5808
    ISSN (online) 2173-5808
    ISSN 2173-5808
    DOI 10.1016/j.nrleng.2023.06.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Effects of social distancing on the incidence of Bell's palsy and sudden sensorineural hearing loss.

    Hafrén, Lena / Saarinen, Riitta / Lundberg, Marie

    Acta oto-laryngologica

    2022  Volume 142, Issue 2, Page(s) 220–223

    Abstract: ... monthly incidence on BP decreased during the COVID-19 pandemic lock-down. No change in the SSNHL incidence ... Background: The aetiology of idiopathic facial nerve palsy (Bell's palsy, BP) and sudden ... of many infectious diseases decreased during the lockdown of the society that took place during the COVID-19 pandemic ...

    Abstract Background: The aetiology of idiopathic facial nerve palsy (Bell's palsy, BP) and sudden sensorineural hearing loss (SSNHL) are not known. It has been proposed that common respiratory tract viruses play a part in the pathophysiology of these diseases.
    Objectives: The incidence of many infectious diseases decreased during the lockdown of the society that took place during the COVID-19 pandemic. We investigated a possible change in the incidence of BP and SSNHL during the lock-down.
    Material and methods: We searched the patient records for all BP and SSNHL cases between 1 Jan 2017 - 31 Aug 2020 at the hospital district of Helsinki and Uusimaa that covers a population of about 1.2 million.
    Results: The mean monthly incidence on BP decreased during the COVID-19 pandemic lock-down. No change in the SSNHL incidence was discovered.
    Conclusions and significance: There is reason to speculate that one aetiologic reason for BP are transmittable respiratory tract pathogens.
    MeSH term(s) Bell Palsy/epidemiology ; Bell Palsy/etiology ; COVID-19/epidemiology ; Communicable Disease Control ; Hearing Loss, Sensorineural/complications ; Hearing Loss, Sensorineural/etiology ; Humans ; Incidence ; Pandemics ; Physical Distancing
    Language English
    Publishing date 2022-01-27
    Publishing country England
    Document type Journal Article
    ISSN 1651-2251
    ISSN (online) 1651-2251
    DOI 10.1080/00016489.2021.2025425
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Increased incidence of idiopathic paediatric facial palsy during the coronavirus disease 2019 pandemic.

    Hogg, E S / Hampton, T / Street, I / Clarke, R / Wright, K / De, S / Sharma, S D

    The Journal of laryngology and otology

    2021  Volume 135, Issue 8, Page(s) 668–670

    Abstract: ... conducted of Bell's palsy cases presenting to our paediatric ENT unit over a 19-week period, from February ... questioned perceived an increased incidence in paediatric Bell's palsy.: Conclusion: Clinicians are ... Background: Bell's palsy is a lower motor neurone facial weakness of unknown aetiology ...

    Abstract Background: Bell's palsy is a lower motor neurone facial weakness of unknown aetiology, although reactivation of a virus within the facial nerve has been proposed.
    Methods: A prospective study was conducted of Bell's palsy cases presenting to our paediatric ENT unit over a 19-week period, from February to June 2020. Patients were invited for severe acute respiratory syndrome coronavirus-2 antibody testing. A text-message questionnaire was sent to other ENT centres to determine their observational experience.
    Results: During the study period, 17 children presented with Bell's palsy, compared with only 3 children in the same time period in the previous year (p < 0.0001). Five patients underwent severe acute respiratory syndrome coronavirus-2 antibody testing, the results of which were all negative. Four out of 15 centres questioned perceived an increased incidence in paediatric Bell's palsy.
    Conclusion: Clinicians are encouraged to be vigilant to the increase in paediatric Bell's palsy seen during the coronavirus disease 2019 pandemic, which may represent a post-viral sequela of coronavirus disease 2019.
    MeSH term(s) Bell Palsy/epidemiology ; Bell Palsy/etiology ; Bell Palsy/virology ; COVID-19/complications ; COVID-19/epidemiology ; Child ; Female ; Humans ; Incidence ; Male ; Prospective Studies ; Surveys and Questionnaires ; United Kingdom/epidemiology
    Language English
    Publishing date 2021-05-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 218299-3
    ISSN 1748-5460 ; 0022-2151
    ISSN (online) 1748-5460
    ISSN 0022-2151
    DOI 10.1017/S0022215121001353
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.

    Voss, Erica A / Shoaibi, Azza / Yin Hui Lai, Lana / Blacketer, Clair / Alshammari, Thamir / Makadia, Rupa / Haynes, Kevin / Sena, Anthony G / Rao, Gowtham / van Sandijk, Sebastiaan / Fraboulet, Clement / Boyer, Laurent / Le Carrour, Tanguy / Horban, Scott / Morales, Daniel R / Martínez Roldán, Jordi / Ramírez-Anguita, Juan Manuel / Mayer, Miguel A / de Wilde, Marcel /
    John, Luis H / Duarte-Salles, Talita / Roel, Elena / Pistillo, Andrea / Kolde, Raivo / Maljković, Filip / Denaxas, Spiros / Papez, Vaclav / Kahn, Michael G / Natarajan, Karthik / Reich, Christian / Secora, Alex / Minty, Evan P / Shah, Nigam H / Posada, Jose D / Garcia Morales, Maria Teresa / Bosca, Diego / Cadenas Juanino, Honorio / Diaz Holgado, Antonio / Pedrera Jiménez, Miguel / Serrano Balazote, Pablo / García Barrio, Noelia / Şen, Selçuk / Üresin, Ali Yağız / Erdogan, Baris / Belmans, Luc / Byttebier, Geert / Malbrain, Manu L N G / Dedman, Daniel J / Cuccu, Zara / Vashisht, Rohit / Butte, Atul J / Patel, Ayan / Dahm, Lisa / Han, Cora / Bu, Fan / Arshad, Faaizah / Ostropolets, Anna / Nyberg, Fredrik / Hripcsak, George / Suchard, Marc A / Prieto-Alhambra, Dani / Rijnbeek, Peter R / Schuemie, Martijn J / Ryan, Patrick B

    EClinicalMedicine

    2023  Volume 58, Page(s) 101932

    Abstract: ... standardised incidence rate ratios (SIR) were estimated to compare post-COVID-19 to pre-pandemic rates ... for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with COVID-19. Our aim was ... in the post-COVID-19 compared to the historical cohorts, with related meta-analytic SIRs ranging from 1.32 (1 ...

    Abstract Background: Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with COVID-19. Our aim was to characterise the incidence rates of AESIs following SARS-CoV-2 infection in patients and compare these to historical rates in the general population.
    Methods: A multi-national cohort study with data from primary care, electronic health records, and insurance claims mapped to a common data model. This study's evidence was collected between Jan 1, 2017 and the conclusion of each database (which ranged from Jul 2020 to May 2022). The 16 pre-specified prevalent AESIs were: acute myocardial infarction, anaphylaxis, appendicitis, Bell's palsy, deep vein thrombosis, disseminated intravascular coagulation, encephalomyelitis, Guillain- Barré syndrome, haemorrhagic stroke, non-haemorrhagic stroke, immune thrombocytopenia, myocarditis/pericarditis, narcolepsy, pulmonary embolism, transverse myelitis, and thrombosis with thrombocytopenia. Age-sex standardised incidence rate ratios (SIR) were estimated to compare post-COVID-19 to pre-pandemic rates in each of the databases.
    Findings: Substantial heterogeneity by age was seen for AESI rates, with some clearly increasing with age but others following the opposite trend. Similarly, differences were also observed across databases for same health outcome and age-sex strata. All studied AESIs appeared consistently more common in the post-COVID-19 compared to the historical cohorts, with related meta-analytic SIRs ranging from 1.32 (1.05 to 1.66) for narcolepsy to 11.70 (10.10 to 13.70) for pulmonary embolism.
    Interpretation: Our findings suggest all AESIs are more common after COVID-19 than in the general population. Thromboembolic events were particularly common, and over 10-fold more so. More research is needed to contextualise post-COVID-19 complications in the longer term.
    Funding: None.
    Language English
    Publishing date 2023-04-04
    Publishing country England
    Document type Journal Article
    ISSN 2589-5370
    ISSN (online) 2589-5370
    DOI 10.1016/j.eclinm.2023.101932
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases

    Erica A. Voss / Azza Shoaibi / Lana Yin Hui Lai / Clair Blacketer / Thamir Alshammari / Rupa Makadia / Kevin Haynes / Anthony G. Sena / Gowtham Rao / Sebastiaan van Sandijk / Clement Fraboulet / Laurent Boyer / Tanguy Le Carrour / Scott Horban / Daniel R. Morales / Jordi Martínez Roldán / Juan Manuel Ramírez-Anguita / Miguel A. Mayer / Marcel de Wilde /
    Luis H. John / Talita Duarte-Salles / Elena Roel / Andrea Pistillo / Raivo Kolde / Filip Maljković / Spiros Denaxas / Vaclav Papez / Michael G. Kahn / Karthik Natarajan / Christian Reich / Alex Secora / Evan P. Minty / Nigam H. Shah / Jose D. Posada / Maria Teresa Garcia Morales / Diego Bosca / Honorio Cadenas Juanino / Antonio Diaz Holgado / Miguel Pedrera Jiménez / Pablo Serrano Balazote / Noelia García Barrio / Selçuk Şen / Ali Yağız Üresin / Baris Erdogan / Luc Belmans / Geert Byttebier / Manu L.N.G. Malbrain / Daniel J. Dedman / Zara Cuccu / Rohit Vashisht / Atul J. Butte / Ayan Patel / Lisa Dahm / Cora Han / Fan Bu / Faaizah Arshad / Anna Ostropolets / Fredrik Nyberg / George Hripcsak / Marc A. Suchard / Dani Prieto-Alhambra / Peter R. Rijnbeek / Martijn J. Schuemie / Patrick B. Ryan

    EClinicalMedicine, Vol 58, Iss , Pp 101932- (2023)

    a multinational retrospective cohort studyResearch in context

    2023  

    Abstract: ... standardised incidence rate ratios (SIR) were estimated to compare post-COVID-19 to pre-pandemic rates ... for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with COVID-19. Our aim was ... in the post-COVID-19 compared to the historical cohorts, with related meta-analytic SIRs ranging from 1.32 (1 ...

    Abstract Summary: Background: Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with COVID-19. Our aim was to characterise the incidence rates of AESIs following SARS-CoV-2 infection in patients and compare these to historical rates in the general population. Methods: A multi-national cohort study with data from primary care, electronic health records, and insurance claims mapped to a common data model. This study's evidence was collected between Jan 1, 2017 and the conclusion of each database (which ranged from Jul 2020 to May 2022). The 16 pre-specified prevalent AESIs were: acute myocardial infarction, anaphylaxis, appendicitis, Bell's palsy, deep vein thrombosis, disseminated intravascular coagulation, encephalomyelitis, Guillain- Barré syndrome, haemorrhagic stroke, non-haemorrhagic stroke, immune thrombocytopenia, myocarditis/pericarditis, narcolepsy, pulmonary embolism, transverse myelitis, and thrombosis with thrombocytopenia. Age-sex standardised incidence rate ratios (SIR) were estimated to compare post-COVID-19 to pre-pandemic rates in each of the databases. Findings: Substantial heterogeneity by age was seen for AESI rates, with some clearly increasing with age but others following the opposite trend. Similarly, differences were also observed across databases for same health outcome and age-sex strata. All studied AESIs appeared consistently more common in the post-COVID-19 compared to the historical cohorts, with related meta-analytic SIRs ranging from 1.32 (1.05 to 1.66) for narcolepsy to 11.70 (10.10 to 13.70) for pulmonary embolism. Interpretation: Our findings suggest all AESIs are more common after COVID-19 than in the general population. Thromboembolic events were particularly common, and over 10-fold more so. More research is needed to contextualise post-COVID-19 complications in the longer term. Funding: None.
    Keywords COVID-19 ; Observational research ; OMOP CDM ; Adverse events of special interest ; Medicine (General) ; R5-920
    Language English
    Publishing date 2023-04-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top